NEU 2.67% $14.56 neuren pharmaceuticals limited

Full year guidance unchanged. So that is $294-$344 million US...

  1. 189 Posts.
    lightbulb Created with Sketch. 362
    Full year guidance unchanged. So that is $294-$344 million US expected in final 3 quarters or an average of $98-$114 million US each quarter. It's pretty clear sales haven't even close to peaked. Meanwhile NEU is printing money for doing nothing while the real prize 2591 bubbles away in the background. Can't understand some of the negativity here to be honest!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.